fda pma申请接受及文档审查准则[2012.07.31].pdf

fda pma申请接受及文档审查准则[2012.07.31].pdf

  1. 1、本文档共30页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Contains Nonbinding Recommendations Draft - Not for Implementation 1 Draft Guidance for Industry and 2 Food and Drug Administration 3 Staff 4 5 6 Acceptance and Filing Review for 7 Premarket Approval Applications 8 (PMAs) 9 10 DRAFT GUIDANCE 11 12 This guidance document is being distributed for comment purposes only. 13 Document issued on: July 31, 2012 14 15 You should submit comments and suggestions regarding this draft document within 45 days of 16 publication in the Federal Register of the notice announcing the availability of the draft guidance. 17 Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug 18 Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic 19 comments to . Identify all comments with the docket number listed in 20 the notice of availability that publishes in the Federal Register . 21 22 For questions regarding this document, contact the Premarket Approval Staff at 301-796-5640. 23 For questions regarding submissions to the Center for Biologics Evaluation and Research, 24 contact CBER’s Office of Communication, Outreach and Development at 1-800-835-4709 or 25 301-827-1800. 26 27 When final, this document will supersede the following guidance documents: 28 Premarket Approval Application Filing Review, dated May 1, 2003. 29 30 U.S. Department of Health and Human Services 31 Food and Drug Administration 32 Center for Devices and Radiological Health 33 Center for Biolo

文档评论(0)

资料 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档